肺栓塞的全身溶栓治疗：综述
Systemic Thrombolysis for Pulmonary Embolism: A Review.
作者信息
Martin Colleen, Sobolewski Kristine, Bridgeman Patrick, Boutsikaris Daniel
出版信息
P T. 2016 Dec;41(12):770-775.
Abstract
The authors review the evidence behind the use of thrombolytic therapy in patients with massive or submassive pulmonary embolism. Concurrent heparin therapy and the management of bleeding episodes are also discussed.
摘要
作者回顾了在大面积或次大面积肺栓塞患者中使用溶栓治疗的相关证据。同时也讨论了肝素联合治疗及出血事件的处理。
相似文献
1
Systemic Thrombolysis for Pulmonary Embolism: A Review.
P T. 2016 Dec;41(12):770-775.
2
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2.
3
Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
J Emerg Med. 2016 Jul;51(1):37-44. doi: 10.1016/j.jemermed.2016.02.024. Epub 2016 Apr 9.
4
Outcomes of Catheter-Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism.
Am J Med. 2019 Feb;132(2):240-246. doi: 10.1016/j.amjmed.2018.10.015. Epub 2018 Oct 24.
5
Should thrombolytic therapy be used in patients with pulmonary embolism?
Am J Cardiovasc Drugs. 2004;4(2):69-74. doi: 10.2165/00129784-200404020-00001.
6
7
Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism.
Patient Prefer Adherence. 2014 Feb 28;8:275-82. doi: 10.2147/PPA.S56280. eCollection 2014.
8
Combined thrombolysis and inferior vena caval interruption as a therapeutic approach to massive and submassive pulmonary embolism.
Conn Med. 2006 Jun-Jul;70(6):367-70.
9
Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
Pharmacology. 2023;108(2):111-126. doi: 10.1159/000527668. Epub 2023 Jan 5.
10
Systemic thrombolysis for acute pulmonary embolism.
Hosp Pract (1995). 2015;43(1):22-7. doi: 10.1080/21548331.2015.1001302. Epub 2015 Jan 6.
引用本文的文献
1
Multiple Therapeutic Modalities in Intermediate-High-Risk Pulmonary Embolism: A Case Report.
Cureus. 2025 Jan 16;17(1):e77543. doi: 10.7759/cureus.77543. eCollection 2025 Jan.
2
Clinical Profile and Outcomes of Pulmonary Embolism in Central Iran: A Retrospective Cohort Study.
Arch Iran Med. 2024 Dec 1;27(12):667-673. doi: 10.34172/aim.31907.
3
Large-bore aspiration thrombectomy for the treatment of pulmonary embolism in octogenarians.
CVIR Endovasc. 2025 Jan 22;8(1):7. doi: 10.1186/s42155-025-00517-2.
4
Mechanical thrombectomy devices for the management of pulmonary embolism.
JVS Vasc Insights. 2024;2. doi: 10.1016/j.jvsvi.2024.100053. Epub 2024 Jan 11.
5
effect of hydroxyethyl starch on COVID-19 patients-associated hypofibrinolytic state.
Res Pract Thromb Haemost. 2024 Mar 15;8(2):102382. doi: 10.1016/j.rpth.2024.102382. eCollection 2024 Feb.
6
What's New in Critical Illness and Injury Science? Alteplase for severe coronavirus disease 2019: Not quite ready to clot bust just hypoxemia.
Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):181-183. doi: 10.4103/ijciis.ijciis_82_22. Epub 2022 Dec 26.
7
Fatal post-operative venous thromboembolism in an adult with Down syndrome.
J Anaesthesiol Clin Pharmacol. 2022 Jul-Sep;38(3):515-516. doi: 10.4103/joacp.JOACP_431_20. Epub 2022 Feb 10.
8
A Brief Review of Thrombolytics for Venous Interventions.
Semin Intervent Radiol. 2022 Nov 17;39(4):394-399. doi: 10.1055/s-0042-1757318. eCollection 2022 Aug.
9
Outcomes of Catheter-Delivered Thrombolytic Therapy and Resuscitative Measures in a Cardiac Arrest Patient With Massive Pulmonary Embolism: A Case Report.
Cureus. 2022 Aug 31;14(8):e28654. doi: 10.7759/cureus.28654. eCollection 2022 Aug.
10
Predicting pulmonary embolism among hospitalized patients with machine learning algorithms.
Pulm Circ. 2022 Jan 11;12(1):e12013. doi: 10.1002/pul2.12013. eCollection 2022 Jan.
本文引用的文献
1
Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
J Emerg Med. 2016 Jul;51(1):37-44. doi: 10.1016/j.jemermed.2016.02.024. Epub 2016 Apr 9.
2
Comparison between systemic and catheter thrombolysis in patients with pulmonary embolism.
Am J Emerg Med. 2016 Jun;34(6):985-8. doi: 10.1016/j.ajem.2016.02.037. Epub 2016 Feb 15.
3
Recent advances in the management of pulmonary embolism: focus on the critically ill patients.
Ann Intensive Care. 2016 Dec;6(1):19. doi: 10.1186/s13613-016-0122-z. Epub 2016 Mar 3.
4
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.
Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7.
5
Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism.
J Thromb Thrombolysis. 2016 Jan;41(1):68-80. doi: 10.1007/s11239-015-1318-z.
6
Guidance for the treatment of deep vein thrombosis and pulmonary embolism.
J Thromb Thrombolysis. 2016 Jan;41(1):32-67. doi: 10.1007/s11239-015-1317-0.
7
Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis.
J Thorac Dis. 2015 May;7(5):810-21. doi: 10.3978/j.issn.2072-1439.2015.04.51.
8
Low-Dose Systemic Alteplase (tPA) for the Treatment of Pulmonary Embolism.
Ann Pharmacother. 2015 Jul;49(7):818-24. doi: 10.1177/1060028015579988. Epub 2015 Apr 9.
9
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.
Eur Heart J. 2014 Dec 1;35(45):3145-6. doi: 10.1093/eurheartj/ehu393.
10
Benefits and risks associated with thrombolysis for pulmonary embolism.
JAMA. 2014 Oct 15;312(15):1588-9. doi: 10.1001/jama.2014.10780.
Zotero 插件